Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
5 hedge funds and large institutions have $47.3K invested in Altamira Therapeutics Ltd in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
551% more capital invested
Capital invested by funds: $7.26K → $47.3K (+$40K)
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$71.9K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$296 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$3.94K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.96K |
| 3 |
Morgan Stanley
New York
|
-$513 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$19 |
CYTO Hedge Fund Activity: Q2 2023 in Review
5 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q2 2023, worth a combined $47.3K — up 551% from $7.26K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CYTO and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $71.9K. The largest seller was Citigroup, exiting entirely with an estimated $3.94K sold.
- 5 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q2 2023, down from 6 in Q1 2023.
- Funds reported $47.3K of Altamira Therapeutics Ltd stock for Q2 2023, up 551% quarter-over-quarter.
- 2 funds opened new Altamira Therapeutics Ltd positions in Q2 2023 and 3 closed out, a net change of -1 holder.
- The largest Altamira Therapeutics Ltd buyer in Q2 2023 was Citadel Advisors, an estimated $71.9K added.
- The largest Altamira Therapeutics Ltd seller in Q2 2023 was Citigroup, an estimated $3.94K sold.
Based on aggregated 13F filings for Q2 2023.